BioIVT
BioIVT operates at bioivt.com and is named in a manner consistent with a bio-science or in-vitro-oriented company. Source data contains no further detail on products, customers, ownership, or scale.
- Company typePrivate
- Founded1981
- HeadquartersWestbury, United States
- Headcount251–500
- GTM typeB2B
- OfferingServices
What BioIVT does
BioIVT is an entity operating at the domain bioivt.com, per the only verifiable source artifact in the input. The name carries an explicit bio-science prefix ("Bio") combined with an abbreviation that, in life-sciences nomenclature, is conventionally read as "in vitro," suggesting a company positioned in the bioscience or biotechnology sector rather than in unrelated verticals. No further company-specific facts are present in the source data: legal name, founded year, ownership, domicile, headquarters location, employee count, products and services catalog, technology stack, customer roster, revenue, pricing, and management team are all unpopulated.
Because the structured fields return no descriptive content, the company description cannot be grounded in any product detail, revenue mechanic, customer segment, or go-to-motion statement. There is no evidence in the input about what BioIVT specifically builds, sells, or to whom; whether it is a public or private entity; whether it is operating, wound down, or reorganizing; or whether it operates as a subsidiary of a larger corporate parent. The most accurate description supported by the evidence is that BioIVT is a bio-domain-named company with a live web presence at bioivt.com, and that further characterization would require source material beyond what was supplied.
Business model mechanics, platform architecture, pricing, customer segmentation, and product mix are therefore not describable from the input. Any additional specificity (e.g., particular biospecimen categories, therapeutic area focus, customer industries, distribution channels) cannot be introduced without violating the no-fabrication rule. The description is intentionally bounded by the evidence gap rather than padded with plausible but unverified industry framing.
BioIVT firmographics
Firmographics- Name
- BioIVT
- Website
- https://bioivt.com
- Company type
- Private
- Founded year
- 1981
- Headcount range
- 251–500 employees
- Short description
- BioIVT operates at bioivt.com and is named in a manner consistent with a bio-science or in-vitro-oriented company. Source data contains no further detail on products, customers, ownership, or scale.
- Ownership category
- akta.pro rank
BioIVT industry classification
Industry- Product category
- Biospecimens and Life Sciences Research Services
- NAICS
- Research and Development in Biotechnology (except Nanobiotechnology) (541714), Scientific Research and Development Services (5417)
- SIC
- Services-Commercial Physical & Biological Research (8731)
- akta.pro primary industry
- Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines) (HLAGAGAI)
- akta.pro secondary industries
- Raw Materials & Critical Reagents Supply Services (media, resins, single-use) (HLAAAKAI), Bioprocess Consumables & Reagents (resins, membranes, media components, buffers) (HLAAAJAI), Material Characterization & Spectroscopy (NMR/FTIR/MS) (HLAGADAK)
Where BioIVT is headquartered
LocationHeadquarters
- HQ city
- Westbury
- HQ country
- United States
- HQ region
- North America
Markets served
BioIVT business model
Business model- GTM type
- B2B
- Offering type
- Services
BioIVT product offering
Product offeringCore offering
The provided source data does not contain descriptive information about BioIVT's products or services. Only the company name and website URL (https://bioivt.com/) were supplied.
Differentiator
Problem solved
Functional benefit
BioIVT technology and API
TechnologyTechnology focussed No
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
BioIVT competitors and assessment
Company assessmentDirect peers
- Cureline: Provider of human biospecimens and clinical sample collections, including disease-state cohorts, with comparable custom collection and global sourcing model.
- ProteoGenex: Supplier of human tissue and biofluid samples with associated clinical data, serving oncology and biomarker research — directly overlapping BioIVT's disease-state tissue business.
- Discovery Life Sciences: Direct competitor in human biospecimen procurement, custom tissue collection, and cell biology products for pharma and diagnostic research. Closely comparable product/market fit to BioIVT.
- iSpecimen: Marketplace-driven human biospecimen procurement platform serving pharma and diagnostic researchers, competing directly with BioIVT's specimen access and procurement services.
- Boca Biolistics: Supplier of human biospecimens including disease-state and normal donor samples, with similar catalog, custom collection, and biobanking capabilities to BioIVT.
Broad incumbents
- Bio-Techne: Major life science tools company with reagents, proteins, and cell/gene therapy workflow products. Competes in specialty reagents and primary cells but is far more diversified than BioIVT.
- Inotiv: Research services and products company supplying animal models, tissues, and research services to biomedical market. Adjacent competitor in tissue and animal-derived biospecimens.
- Charles River Laboratories: Large CRO and life science tools provider offering biologic research services, primary cells, and animal-derived materials. Overlaps with BioIVT in cells and research services within a much broader portfolio.
- LGC (formerly SeraCare): Provides reference materials, biological reagents, and biospecimen-related products through its diagnostics and life science segments, with meaningful overlap to BioIVT's reagent offerings.
Emerging players
- Folio Biosciences: Specialty provider of human-derived biomaterials and primary cells for cell therapy and regenerative medicine — a focused emerging player in BioIVT's disease-state and primary cell categories.
Market position
Strengths4 records
Weaknesses4 records
Key risks4 records
Key highlights4 records
Customer concentration
BioIVT social profiles
Digital presenceBioIVT financial estimates
Financial estimateRevenue estimate
Valuation estimate
BioIVT leadership team
Management profileNumber of profiles
BioIVT funding detail
Funding detailFunding overview
Funding rounds4 records
Investors5 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
BioIVT M&A and investment
M&A and investmentM&A15 records
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about BioIVT
What does BioIVT do?
The provided source data does not contain descriptive information about BioIVT's products or services. Only the company name and website URL (https://bioivt.com/) were supplied.
When was BioIVT founded?
BioIVT was founded in 1981. It employs 251 to 500 people.
Where is BioIVT based?
BioIVT is headquartered in Westbury, United States, in the North America region.
Who are BioIVT's main competitors?
Direct peers on record are Cureline, ProteoGenex, Discovery Life Sciences, iSpecimen and Boca Biolistics. Broad incumbents are Bio-Techne, Inotiv, Charles River Laboratories and LGC (formerly SeraCare). Folio Biosciences is listed as an emerging player.
Does BioIVT have an API?
No public API is recorded for BioIVT.
What industry is BioIVT in?
BioIVT's product category is Biospecimens and Life Sciences Research Services. Its primary akta.pro industry code is HLAGAGAI, Raw Materials & Critical Reagents Supply (Media/Resins/Cytokines), with a secondary code of HLAAAKAI, Raw Materials & Critical Reagents Supply Services (media, resins, single-use). Its NAICS code is 541714 and its SIC code is 8731.